NUMEDISYN Trademark
Trademark Overview
On Monday, August 25, 2025, a trademark application was filed for NUMEDISYN with the United States Patent and Trademark Office. The USPTO has given the NUMEDISYN trademark a serial number of 99357110. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, March 10, 2026. This trademark is owned by NUMEDISYN LLC. The NUMEDISYN trademark is filed in the Pharmaceutical Products category with the following description:
Biologics in the nature of therapeutic agents designed to mitigate autoimmune dysfunction inherent to rheumatoid arthritis, multiple sclerosis, autoimmune diseases, diseases carrying autoimmune components, neurologic diseases, neurodegenerative diseases and cardiovascular diseases; Medical food in the nature of defined nutritional therapeutic preparations, that cannot be replicated through diet alone, designed for the medical, supervised management of conditions displaying dysregulation in the key metabolic pathways related to cellular methylation cycle, neurodegenerative diseases, neurologic diseases and cardiovascular diseases
General Information
| Serial Number | 99357110 |
| Word Mark | NUMEDISYN |
| Filing Date | Monday, August 25, 2025 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, March 10, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 10, 2026 |
Trademark Statements
| Pseudo Mark | NEW MEDICINE |
| Goods and Services | Biologics in the nature of therapeutic agents designed to mitigate autoimmune dysfunction inherent to rheumatoid arthritis, multiple sclerosis, autoimmune diseases, diseases carrying autoimmune components, neurologic diseases, neurodegenerative diseases and cardiovascular diseases; Medical food in the nature of defined nutritional therapeutic preparations, that cannot be replicated through diet alone, designed for the medical, supervised management of conditions displaying dysregulation in the key metabolic pathways related to cellular methylation cycle, neurodegenerative diseases, neurologic diseases and cardiovascular diseases |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, August 25, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | NUMEDISYN LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Concord, NC 28025
US |
| Party Name | NUMEDISYN LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Concord, NC 28025
US |
Trademark Events
| Event Date | Event Description |
| Monday, August 25, 2025 | NEW APPLICATION ENTERED |
| Monday, August 25, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, August 26, 2025 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, October 29, 2025 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Wednesday, October 29, 2025 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, October 29, 2025 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, January 12, 2026 | ASSIGNED TO EXAMINER |
| Thursday, January 22, 2026 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, January 22, 2026 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, January 22, 2026 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, January 22, 2026 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, February 17, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 4, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, March 10, 2026 | PUBLISHED FOR OPPOSITION |
| Tuesday, March 10, 2026 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
